secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2023-07-25T23:59:59+00:00
Accession:  0001477449-23-000005
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Health Q2 revenue $652M (+10% YoY); adj EBITDA $72.2M beats outlook
---------------------------------------------------------------------------

- Revenue $652.4M (+10% YoY); Integrated Care $360.1M (+5%), BetterHelp $292.4M (+18%).
- Net loss $65.2M ($0.40/share) vs $3.1B loss in Q2 2022 which included $3.03B goodwill impairment.
- Adjusted EBITDA $72.2M (+54% YoY), exceeding expectations; operating cash flow $101.2M.
- Q3 2023 guidance: revenue $650-$675M, adj EBITDA $72-$82M; full-year adj EBITDA $300-$325M.
- U.S. Integrated Care members guided at ~86 million for Q3 and full year 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744923000005/0001477449-23-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744923000005/tdoc-20230725.htm
  HTML page:      https://secwatch.observer/filing/0001477449-23-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer